E-mail

E-mail a Wiley Online Library Link

Daniel A. Anaya, Yan Xing, Lei Feng, Xuelin Huang, Luis H. Camacho, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Paul F. Mansfield and Janice N. Cormier Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease Cancer 112

Version of Record online: 4 MAR 2008 | DOI: 10.1002/cncr.23399

In this retrospective review, the authors found that the use of adjuvant high-dose interferon for patients with stage III melanoma was associated with improved recurrence-free survival, with the most striking benefit noted for patients with stage IIIA disease.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH